Related Experiment Videos

[Serum apolipoprotein AI, B levels in patients with coronary diseases]

Y He1

  • 1Fourth Military Medical University, Xian.

Insights

Apolipoproteins A1 and B, and their ratio, are more effective than traditional lipid profiles in assessing coronary artery disease (CAD) severity and distinguishing it from other conditions.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Medical Diagnostics

Context:

  • Coronary artery disease (CAD) diagnosis relies on various biomarkers.
  • Traditional lipid profiles (total cholesterol, triglycerides, LDL-C, HDL-C) are commonly used.
  • The diagnostic and prognostic value of apolipoproteins in CAD requires further investigation.

Purpose:

  • To compare the efficacy of apolipoprotein A1 (apo A1), apolipoprotein B (apoB), and the apoB/apoA1 ratio against standard lipid profiles for CAD assessment.
  • To evaluate these markers in differentiating CAD severity, including angina and myocardial infarction.

Summary:

  • Serum levels of total cholesterol, triglycerides, LDL-C, HDL-C, apo A1, and apoB were measured in 100 CAD patients and 141 controls.
  • Significant differences were observed in these variables between CAD and non-CAD groups, as well as between angina and myocardial infarction subgroups.
  • Regression analysis indicated that apo A1 and the apoB/apoA1 ratio are more sensitive and specific than traditional lipid indices for estimating coronary artery stenosis and differentiating CAD.

Impact:

  • Apolipoprotein markers offer improved accuracy in diagnosing and assessing the severity of coronary artery disease.
  • This finding can lead to more precise diagnostic tools and personalized treatment strategies for CAD patients.
  • Enhanced differentiation of CAD from other conditions using these biomarkers can optimize clinical decision-making.

Related Concept Videos